Skip to main content
. 2017 Jun 15;7(6):e014218. doi: 10.1136/bmjopen-2016-014218

Figure 2.

Figure 2

Effects of LPIDs co-administration on occurrence of hypokalaemia in patients treated with YK preparations. Solid line: patients co-administered with LPIDs; dotted line: patients without LPIDs co-administration. A significant difference was observed between patients with and without LPIDs co-administration in the log-rank test (p<0.001). LPIDs, lower potassium-inducing drug; YK, Yokukansan.